Caxton Corp as of Sept. 30, 2017
Portfolio Holdings for Caxton Corp
Caxton Corp holds 16 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Strongbridge Bioph shs usd | 38.7 | $38M | 5.5M | 6.90 | |
| Spdr S&p 500 Etf (SPY) | 19.7 | $19M | 77k | 251.23 | |
| Kala Pharmaceuticals | 12.7 | $12M | 544k | 22.84 | |
| Agile Therapeutics | 8.3 | $8.1M | 1.8M | 4.46 | |
| Garrison Capital | 7.3 | $7.2M | 850k | 8.43 | |
| Molecular Templates | 7.2 | $7.1M | 1.0M | 6.97 | |
| Berkshire Hathaway (BRK.B) | 1.7 | $1.6M | 8.9k | 183.34 | |
| Jbg Smith Properties (JBGS) | 1.3 | $1.2M | 36k | 34.21 | |
| Intec Pharma | 0.7 | $681k | 76k | 8.94 | |
| Cm Fin | 0.6 | $574k | 61k | 9.34 | |
| Gtx Inc Del | 0.5 | $531k | 63k | 8.45 | |
| Adient (ADNT) | 0.4 | $398k | 4.7k | 84.02 | |
| Team Health Holdings | 0.3 | $335k | 7.7k | 43.46 | |
| Jazz Pharmaceuticals (JAZZ) | 0.3 | $306k | 2.0k | 153.23 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $263k | 10k | 25.85 | |
| Marinus Pharmaceuticals | 0.1 | $95k | 16k | 5.86 |
